Clinical

Dataset Information

0

GEN1029 (HexaBody-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors


ABSTRACT: The purpose of the trial is to evaluate the safety of GEN1029 (HexaBody-DR5/DR5) in a mixed population of patients with specified solid tumors

DISEASE(S): Urothelial Cancer,Triple Negative Breast Neoplasms,Gastric Cancer,Colorectal Cancer,Non-small Cell Lung Cancer,Malignant Solid Tumors: patients With Advanced And/or Metastatic Colorectal Cancer (crc), Non-small Cell Lung Cancer (nsclc), Triple Negative Breast Cancer (tnbc), Renal Cell Carcinoma (rcc), Gastric (incl. Esophagogastric Junction) Cancer, Pancreatic Cancer Or Urothelial Cancer.,Carcinoma, Renal Cell,Triple Negative Breast Cancer,Pancreatic Cancer,Renal Cell Carcinoma,Malignant Solid Tumour,Malignant Solid Tumors:patients With Advanced And/or Metastatic Colorectal Cancer (crc), Non-small Cell Lung Cancer (nsclc), Triple Negative Breast Cancer (tnbc), Renal Cell Carcinoma (rcc), Gastr...

PROVIDER: 2276842 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| PRJNA863562 | ENA
2023-05-22 | PXD037429 | Pride
| PRJNA615692 | ENA
| PRJNA615693 | ENA
| 2315820 | ecrin-mdr-crc
| EGAS00001002528 | EGA
| PRJNA823800 | ENA
| PRJNA823801 | ENA
| PRJEB32931 | ENA
2019-10-25 | GSE124888 | GEO